Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",2603,303,1.53 [1.31-1.79],7.899582006033697e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,2633,311,2.71 [2.02-3.64],2.935032206091891e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,2626,305,1.69 [1.39-2.06],1.7308437082245796e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2268,253,2.21 [1.58-3.08],2.9625914735425124e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,2633,311,1.99 [1.57-2.52],1.5728509553847177e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,2665,309,1.91 [1.39-2.61],5.313569955445373e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,2666,313,2.01 [1.54-2.62],2.465384896006869e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,2639,307,1.22 [1.13-1.33],1.681752123238047e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADM,Pro-adrenomedullin,2668,312,2.21 [1.52-3.21],3.412201284602759e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFM,Afamin,2278,252,0.31 [0.18-0.51],5.971395406935761e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,2626,310,0.68 [0.58-0.80],2.050524640656464e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,2564,298,1.22 [1.11-1.34],3.063938297798612e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,2665,309,1.65 [1.30-2.09],3.3728826197368766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,2667,312,3.20 [2.05-4.99],2.859778931590025e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,2660,308,1.60 [1.28-1.99],3.649414963247824e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,2576,301,1.69 [1.32-2.16],2.984420077616944e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,2655,309,3.03 [2.22-4.13],3.345243428274192e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,2278,252,2.55 [1.93-3.36],3.868634639889207e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,2639,307,1.92 [1.60-2.30],1.7534652594833437e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART3,Ecto-ADP-ribosyltransferase 3,2655,309,1.69 [1.32-2.17],3.2395567626571584e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,2268,253,2.09 [1.52-2.88],5.599647695986705e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,2278,252,2.07 [1.48-2.88],1.7275628553137344e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2230,249,2.25 [1.63-3.11],7.809608908154479e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,2583,300,1.85 [1.39-2.45],2.011045111750713e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,2634,311,0.46 [0.35-0.60],1.0380322977411904e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,2286,255,0.73 [0.65-0.82],1.582973217159697e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP10,Bone morphogenetic protein 10,2242,246,2.07 [1.48-2.89],2.041675547676987e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,2603,303,2.70 [1.81-4.03],1.0480133718009978e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,2665,309,2.41 [1.82-3.21],1.1249035740296855e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,2219,248,2.29 [1.66-3.15],4.2023662855283364e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,2639,307,2.73 [2.12-3.52],6.919618184165904e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,2668,312,1.50 [1.27-1.77],1.7961476135219632e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB2,Calretinin,2581,302,1.80 [1.36-2.37],3.724127086942637e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCA,Calcitonin,2631,310,1.33 [1.16-1.53],4.600454421204067e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,2674,311,1.89 [1.45-2.48],3.447320599334101e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,2679,313,1.63 [1.34-1.98],1.0676485976837673e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,2674,311,1.81 [1.47-2.24],2.5031818024005764e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN5,CCN family member 5,2661,313,1.67 [1.32-2.12],2.5425787088528947e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,2674,311,1.74 [1.45-2.09],2.628719417636218e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD207,C-type lectin domain family 4 member K,2599,307,1.65 [1.30-2.11],4.7621023810107474e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,2658,311,2.08 [1.72-2.52],9.411664622551153e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,2649,308,2.67 [2.09-3.42],3.293925611908431e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD28,T-cell-specific surface glycoprotein CD28,2583,300,1.79 [1.40-2.29],3.7971367228508497e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300C,CMRF35-like molecule 6,2673,312,1.82 [1.40-2.37],6.885187707248966e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,2639,307,2.33 [1.82-2.98],2.4579692420085843e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,2667,312,1.65 [1.30-2.11],4.86920710933914e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,2533,299,2.22 [1.58-3.12],4.602511925719024e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,2673,312,2.15 [1.65-2.79],1.2131741820587225e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,2674,311,1.58 [1.30-1.93],4.8816117679142975e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,2547,296,2.00 [1.69-2.38],1.230062082791701e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH15,Cadherin-15,2670,311,1.26 [1.12-1.42],9.651342085982772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,2648,308,1.40 [1.24-1.58],5.4133686907324256e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,2648,308,1.58 [1.28-1.93],1.2860242399896666e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,2242,246,0.55 [0.44-0.69],9.44258492887281e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2278,254,2.08 [1.64-2.63],1.3581299588607915e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGB,Secretogranin-1,2664,310,1.61 [1.31-1.97],4.429865138834328e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,2662,311,2.08 [1.63-2.65],3.657456939597702e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKB,Creatine kinase B-type,2286,255,1.44 [1.21-1.72],5.909469619733815e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,2661,313,1.84 [1.40-2.40],9.668686932305038e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,2215,240,0.31 [0.18-0.53],1.8470996098367843e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC7A,C-type lectin domain family 7 member A,2674,311,1.51 [1.24-1.84],4.6996755324202166e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,2653,313,2.76 [1.91-4.00],6.223738474924215e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,2648,308,1.73 [1.41-2.11],9.732462074575858e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,2679,313,1.90 [1.52-2.36],1.3216441474466517e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,2649,308,2.28 [1.67-3.10],1.768919424405977e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,2669,311,1.56 [1.38-1.77],8.29444640198016e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP3,Cysteine-rich secretory protein 3,2269,253,0.40 [0.26-0.62],4.8663986400605054e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,2648,309,1.96 [1.48-2.60],3.0457842507219244e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2658,311,2.23 [1.73-2.89],9.932840269800755e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,2603,303,2.98 [2.08-4.25],1.989378731842941e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,2630,310,1.71 [1.42-2.06],1.488936249842268e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,2658,311,2.37 [1.81-3.10],4.3929980094758757e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,2230,249,0.62 [0.52-0.73],4.979138564561346e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,2639,307,1.71 [1.32-2.20],3.704616217605886e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,2633,307,2.42 [1.89-3.12],4.8007825116370046e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,2661,313,1.93 [1.43-2.59],1.5211208470437194e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,2668,312,2.18 [1.81-2.63],2.3915008093196943e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,2268,253,2.07 [1.46-2.93],4.663954452908699e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2652,309,1.75 [1.32-2.31],8.749510374690555e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,2659,313,2.41 [1.85-3.14],4.974355932846084e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,2633,311,2.71 [2.16-3.40],7.520327615618367e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,2553,298,2.41 [1.93-3.01],5.183817616711641e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,2679,313,2.50 [1.83-3.40],6.5792323809697e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPO,Erythropoietin,2646,311,1.30 [1.16-1.45],6.187513503280708e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2664,312,1.74 [1.33-2.28],4.863404036893833e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",2649,308,1.24 [1.12-1.37],1.710901443028242e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP3,"Fatty acid-binding protein, heart",2273,252,1.52 [1.26-1.84],9.295598245503144e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",2679,313,1.62 [1.39-1.89],4.6218312486660814e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,2639,307,2.25 [1.70-2.99],1.7996203315159542e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,2647,307,2.93 [2.24-3.83],4.45788398831392e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,2268,253,1.48 [1.29-1.70],1.5642765545406117e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,2585,303,2.16 [1.64-2.84],3.7580288725217786e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,2658,311,0.52 [0.39-0.69],4.612739369080167e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP2,Fibroblast growth factor-binding protein 2,2286,255,0.61 [0.48-0.77],2.842177549275936e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FN1,Fibronectin,2278,252,0.39 [0.25-0.62],5.216609799189721e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL1,Follistatin-related protein 1,2230,249,2.87 [1.74-4.74],3.591382495364448e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,2649,307,1.89 [1.47-2.44],7.892576372739063e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,2585,303,1.59 [1.28-1.97],2.252791814063e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,2583,300,1.22 [1.13-1.31],5.928669514245309e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,2679,313,2.04 [1.78-2.32],4.466097791175809e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,2663,312,2.62 [1.97-3.48],3.916178446190296e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,2634,311,2.78 [1.94-3.98],2.430556044460888e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,2588,299,2.64 [1.88-3.69],1.7477538588965243e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,2603,303,1.35 [1.17-1.56],4.856941012832428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,2648,313,2.45 [1.69-3.56],2.2597801312860494e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,2652,312,1.91 [1.54-2.38],6.895275568957108e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,2667,312,1.69 [1.50-1.89],4.7327557089065335e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,2661,313,1.69 [1.31-2.18],5.693327303489108e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,2273,252,3.41 [2.18-5.33],8.067711870568957e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2646,311,1.94 [1.48-2.55],1.6894951497086949e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB6,Heat shock protein beta-6,2668,312,1.66 [1.34-2.07],4.77306155186846e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2626,304,1.82 [1.36-2.44],6.041942057611679e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,2674,313,1.40 [1.21-1.61],3.224446668494016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,2635,309,1.69 [1.44-1.99],8.369032210723421e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP6,Insulin-like growth factor-binding protein 6,2638,306,1.69 [1.32-2.17],2.831523169070025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15,Interleukin-15,2646,311,1.77 [1.34-2.36],7.453757542886562e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,2585,303,1.35 [1.22-1.50],7.302774810656445e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,2655,309,1.93 [1.46-2.54],3.3299500361537385e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,2659,313,3.63 [2.58-5.10],1.139675594266247e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL1,Interleukin-1 receptor-like 1,2671,313,1.77 [1.41-2.22],6.910427451638597e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,2624,305,1.56 [1.26-1.95],6.553004472887461e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,2585,303,2.09 [1.52-2.87],5.980267652584476e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2655,309,1.70 [1.31-2.22],8.54402811377976e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,2673,312,2.86 [2.16-3.80],3.3098962363715337e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,2630,309,1.78 [1.34-2.37],7.546173818263179e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,2668,312,1.69 [1.50-1.91],3.226845388031793e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,2674,311,2.19 [1.78-2.71],2.323886828323934e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",2641,310,1.46 [1.30-1.65],4.919703531197085e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,2639,307,1.64 [1.33-2.03],4.802814702379181e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2649,308,1.70 [1.43-2.04],4.572811524200278e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,2631,310,2.32 [1.90-2.84],1.954457051086107e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,2649,308,1.69 [1.45-1.97],1.1259584323825648e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,2646,311,3.09 [2.21-4.32],4.8337116255887955e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD1,Leiomodin-1,2274,254,2.14 [1.57-2.91],1.2343779948674397e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,2679,313,1.96 [1.49-2.59],1.4722200109916226e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY6D,Lymphocyte antigen 6D,2642,307,1.52 [1.24-1.87],6.009346578397306e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC2,MAM domain-containing protein 2,2273,252,1.91 [1.41-2.57],2.603704912681392e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,2655,309,1.75 [1.36-2.25],1.4130779520996269e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,2651,310,1.42 [1.21-1.67],2.354738995830456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,2652,311,1.44 [1.22-1.71],2.5116683380495064e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,2599,303,1.67 [1.36-2.04],8.311092314577692e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSR1,Macrophage scavenger receptor types I and II,2673,312,1.61 [1.30-2.00],1.2561939686813212e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,2581,302,1.77 [1.55-2.03],1.3947662626614018e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,2658,311,2.17 [1.59-2.96],8.837983882724444e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,2673,312,0.53 [0.42-0.67],1.724277078618948e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,2642,310,1.80 [1.42-2.28],9.460068982463376e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2268,253,2.06 [1.50-2.83],8.036705995141524e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,2668,312,2.85 [2.07-3.92],1.079153017447126e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,2647,307,2.20 [1.69-2.85],3.173484487668514e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,2658,311,1.87 [1.53-2.29],1.1121890890088316e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,2574,301,1.90 [1.60-2.26],2.332443536296199e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,2658,311,0.59 [0.48-0.72],4.513709687778077e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,2674,311,2.54 [1.90-3.40],4.1350042301095e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,2251,253,2.15 [1.55-3.00],5.728263825369419e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPDC1,Neural proliferation differentiation and control protein 1,2648,308,1.72 [1.36-2.16],5.090552040374057e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,2655,309,2.13 [1.51-2.99],1.4333963528779903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,2661,313,1.61 [1.32-1.95],2.2257148686923942e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH7,Protocadherin-7,2268,253,1.87 [1.45-2.41],1.7131705479808997e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,2639,307,2.32 [1.77-3.02],6.265575242201985e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRA,Platelet-derived growth factor receptor alpha,2648,308,1.98 [1.45-2.71],2.005927873902093e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGF,Placenta growth factor,2674,311,2.17 [1.58-2.99],1.6631491743514728e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,2624,307,2.00 [1.57-2.56],2.1790216040446705e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2661,313,2.62 [2.03-3.38],1.460546646312374e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,2661,313,1.59 [1.26-2.01],9.894900665907764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,2634,311,1.43 [1.21-1.69],2.5086462848354604e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,2661,313,0.41 [0.32-0.53],8.512510421456428e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAT,Tissue-type plasminogen activator,2671,313,0.65 [0.55-0.78],3.848614552510548e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,2636,308,2.27 [1.64-3.16],8.987520941148955e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,2665,312,2.85 [2.11-3.84],8.161369579507324e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,2214,250,1.71 [1.38-2.12],8.954686614789751e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2274,254,1.66 [1.32-2.08],1.2253562103426882e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAP1,Proline-rich acidic protein 1,2286,255,1.92 [1.41-2.61],3.442022286141977e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,2647,309,1.76 [1.40-2.21],9.001148415347526e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,2634,311,1.25 [1.14-1.37],2.226968948633658e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,2622,305,1.89 [1.49-2.41],1.7619912424870137e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTK7,Inactive tyrosine-protein kinase 7,2581,302,1.76 [1.36-2.28],2.1086602830174628e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,2202,248,1.26 [1.14-1.38],3.213816108321448e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6A,Ras-related protein Rab-6A,2646,311,0.62 [0.51-0.77],6.664232480193914e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP2,Retinol-binding protein 2,2639,307,1.28 [1.14-1.43],4.1556594519258e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,2628,304,1.95 [1.69-2.24],2.598649005806196e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,2679,313,1.61 [1.41-1.85],3.9763212737424695e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,2679,313,1.48 [1.30-1.68],1.3074339410860855e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,2656,308,1.97 [1.70-2.27],1.3636851553771708e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,2648,308,1.43 [1.30-1.56],5.922554956097987e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE1,Ribonuclease pancreatic,2287,256,2.21 [1.50-3.27],6.462472782803605e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,2273,255,1.68 [1.35-2.09],3.67963974894225e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,2671,313,2.14 [1.68-2.72],5.462878446229526e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,2230,249,2.06 [1.46-2.91],3.93977840123552e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,2668,312,2.02 [1.52-2.67],1.079889929452773e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,2673,312,2.90 [2.23-3.79],4.382291045670533e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,2576,305,2.08 [1.66-2.60],1.8901957697245927e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,2673,312,2.24 [1.69-2.97],1.7113554736412572e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,2660,312,2.16 [1.69-2.77],1.1935681638120403e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,2585,303,1.80 [1.52-2.13],9.461743385226372e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEL1L,Protein sel-1 homolog 1,2230,249,1.80 [1.45-2.25],1.9000664003692254e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN8,Septin-8,2275,254,2.02 [1.45-2.82],2.962392340637479e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHISA5,Protein shisa-5,2286,255,2.04 [1.46-2.87],3.4112801930594366e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,2668,312,1.91 [1.44-2.54],8.487000253824685e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,2644,308,1.54 [1.27-1.88],1.5958481787486383e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF1,Signaling lymphocytic activation molecule,2585,303,1.45 [1.22-1.72],1.9199978383566733e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,2603,303,1.82 [1.40-2.36],6.188765864597277e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD5,Mothers against decapentaplegic homolog 5,2639,307,0.35 [0.21-0.58],5.384193239867689e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCG,Gamma-synuclein,2634,311,1.44 [1.25-1.66],6.921169826743301e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORCS2,VPS10 domain-containing receptor SorCS2,2583,300,1.75 [1.38-2.23],4.666857185817351e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,2661,313,1.99 [1.70-2.32],5.0624327194552864e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,2646,311,1.64 [1.45-1.84],4.179514016612783e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,2634,311,0.42 [0.29-0.60],1.788421109804152e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,2656,308,1.89 [1.44-2.46],3.445289275571496e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON2,Spondin-2,2640,307,1.73 [1.34-2.24],2.579291993448406e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2639,307,1.46 [1.21-1.75],7.472999138067475e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAFA5,Chemokine-like protein TAFA-5,2639,307,1.64 [1.31-2.05],1.538527375435539e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,2674,313,2.10 [1.56-2.83],1.1201646605103958e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,2650,313,1.37 [1.24-1.51],8.647922040203211e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,2660,308,1.55 [1.35-1.78],4.821322150971031e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,2632,308,1.74 [1.50-2.02],3.101784365838856e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,2658,311,1.84 [1.49-2.27],1.0220821072206932e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,2639,307,1.32 [1.19-1.47],4.0817566389577364e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2634,311,1.90 [1.54-2.35],2.471106990419941e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2634,311,1.37 [1.22-1.54],1.3333443429431304e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2674,311,2.11 [1.74-2.56],5.16828542457453e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2658,311,2.02 [1.60-2.54],2.4001932665051822e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2656,308,2.19 [1.72-2.79],2.819606631727101e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2668,312,1.88 [1.50-2.36],4.734062458043446e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2661,313,2.56 [2.00-3.28],1.0241745591037945e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2661,313,1.53 [1.29-1.80],5.848173129446804e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2669,311,1.97 [1.59-2.43],4.866319554447944e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2634,311,1.58 [1.31-1.89],8.511497355030282e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,2665,309,2.31 [1.64-3.24],1.6517073054993426e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ULBP2,UL16-binding protein 2,2634,311,1.81 [1.44-2.28],5.040122982823288e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASN,Vasorin,2602,300,2.02 [1.45-2.81],3.516150300968681e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,2670,310,1.93 [1.51-2.46],1.4958383540622306e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,2267,249,1.36 [1.18-1.57],1.86324120991261e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,2656,312,1.84 [1.50-2.24],2.8812814756954673e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,2518,287,1.79 [1.48-2.16],1.924239117386593e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,2585,303,1.86 [1.49-2.32],4.3467136613476766e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,2667,312,1.82 [1.42-2.34],2.979337828336863e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YAP1,Transcriptional coactivator YAP1,2278,254,2.57 [1.79-3.69],2.830214581564467e-07
